On Friday, March 6, the Chinese subsidiary of Dutch semiconductor company Nexpria revealed that the headquarters in the Netherlands cut off the office accounts of all employees in the China region starting from 7 p.m. local time on March 3, causing disruptions in some production processes.
According to a statement posted on WeChat by Nexpria China, this action has led to Chinese employees being unable to access key office software such as Office365, SAP system, impacting the operations of Nexpria China.
Nexpria China also mentioned that certain production processes, such as the “SAP ordering process for customer-supplied wafers upon arrival at the factory,” experienced interruptions, but orders that had been entered into the SAP system and were already in the production process were not affected.
The statement noted that at present, most of the business operations in the China region have resumed.
This indicates that the power struggle within Nexpria management, which has been going on for over five months, is still ongoing.
Following this, Nexpria Netherlands disputed the latest claims made by its Chinese subsidiary.
According to Reuters, Nexpria Netherlands stated in a release that the headquarters manages the IT environment in accordance with company policies and applicable regulations, refuting the claims made by the Chinese subsidiary about the inability of ATGD to supply finished products, which they deemed misleading. ATGD refers to the packaging and testing factory located in Dongguan, Guangdong, China.
Nexpria Netherlands is owned by the Chinese technology company Wen Tai, however, the conflict between Nexpria’s management and Wen Tai has escalated beyond the internal operations of the company. In the context of geopolitical tensions, this has evolved into a national security game between China and the Netherlands over “technological sovereignty.”
The Chinese subsidiary of Nexpria has declared its independence from the headquarters and stated that they will no longer follow the directives of the European management team.
An insider from Nexpria reportedly revealed to mainland media Caixin that in October 2025, Nexpria Netherlands had already revoked system permissions for some Chinese employees, deleted their emails and accounts. The latest development is the complete cutting off of all Chinese employees’ office accounts, affecting the production scheduling of the packaging and testing assembly lines.
The Epoch Times reporter could not verify this information. As of the deadline for this article, both Nexpria Netherlands and Nexpria China have not responded to requests for comment from The Epoch Times.
On January 14, 2026, a public hearing on the relevant disputes of Nexpria was held in the Dutch Business Court, focusing on whether an investigation should be initiated into the allegations made by the European management of Nexpria, and considering whether to revoke the interim measures previously taken by the court.
A month later, the Dutch Business Court ruled for a formal investigation into Nexpria, expanding the scope to include the actions of the local management of Nexpria. During the investigation, the interim measures taken by the court, including restrictions on specific personnel positions and shareholder rights, remained in effect, however, the trustee of the shares could not dispose of them. This means that during the investigation, Wen Tai’s control over Nexpria remains restricted, with uncertainty about the timeline of the investigation.
Due to a dispute over unpaid payments by the Chinese factory, Nexpria was forced to halt the supply of wafers.
Nexpria halts supply to Chinese wafer plant, escalating the dispute.
Dutch Prime Minister: Legal proceedings against Nexpria CEO Zhang Xuezheng remain effective.
Dutch Minister reveals insider details of Nexpria dispute, likening it to an economic thriller.
Nexpria accuses Chinese boss of intimidation, sparking a heated battle during the hearing.